PMV Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on PMV Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how PMV Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with PMV Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
PMV Pharmaceuticals Inc (PMV Pharma) is a clinical-stage company which focuses on the development of precision oncology therapies. It carries out the discovery and development of small molecule therapeutics that target mutant p53 proteins. The company's lead product candidate rezatapopt pinnacle treats tumor agnostic; and rezatapopt and azacitidine which targets relapsed and refractory acute myeloid leukemia and myelodysplastic syndromes. PMV Pharma is also investigating PMV-586-101, indication for patients with advanced solid tumors harboring a p53 Y220C mutation. PMV Pharma is headquartered in Princeton, New Jersey, the US.
Headquarters
United States of America
Address
400 Alexander Park Drive, Suite 301, Princeton, New Jersey, 08540
Website
www.pmvpharma.com
Telephone
1 609 6426670
No of Employees
54
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
PMVP (NASD)
EPS
XYZ
Net Income (2024)
XYZ
-32.4%
(2024 vs 2023)
Market Cap*
$62.9M
* As of and is in US$
PMV Pharmaceuticals Inc premium industry data and analytics
Products and Services
| Products |
|---|
| Pipeline: |
| Rezatapopt (PC14586): Tumor Agnostic |
| PMV-586-101: Advanced Solid Tumors |
| XYZ |
| XYZ |
| XYZ |
Competitor Comparison
| Key Parameters | PMV Pharmaceuticals Inc | Kymera Therapeutics Inc | Kronos Bio Inc | Jacobio Pharmaceuticals Group Co Ltd | Ascentage Pharma Group Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | China | United States of America |
| City | Princeton | Watertown | San Mateo | Beijing | Rockville |
| State/Province | New Jersey | Massachusetts | California | Beijing | Maryland |
| No. of Employees | 54 | 238 | 8 | 196 | - |
| Entity Type | Public | Public | Private | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Laurie Stelzer | Chairman | Executive Board | 2026 | 58 |
| David H. Mack, Ph.D | Director; President; Chief Executive Officer | Executive Board | 2013 | 64 |
| Michael Carulli | Chief Financial Officer | Senior Management | 2024 | 52 |
| Robert Ticktin | General Counsel; Chief Operating Officer | Senior Management | 2024 | 64 |
| Marc Fellous, MD | Head - Clinical Development and Medical Affairs; Senior Vice President | Senior Management | 2022 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer